Chris Jeffries

Chris Jeffries is a Senior Director at Catalyst Pharmaceuticals, Inc. since April 2024, with extensive experience in financial roles across multiple pharmaceutical companies. Previously, Chris held the position of Senior Director, Financial Planning & Analysis at Impel Pharmaceuticals from October 2021 to April 2024, and served as Senior Finance Director at Kyowa Kirin, Inc. - U.S. from October 2012 to October 2021. Earlier roles include Senior Director Finance, Controller, and Assistant Controller at EKR Therapeutics, as well as Assistant Controller positions at Esprit Pharma and ESP Pharma. Chris began a financial career as a Senior Financial Analyst at Baxter and Warner Lambert and was a Financial Analyst at AT&T. The early career included a role as a Senior Auditor at Arthur Andersen, LLP. Chris holds an MBA in Finance from Seton Hall University and a degree from the University of Delaware.